Procter & Gamble launches Clearblue menopause indicator test


Procter & Gamble on Aug. 29 announced what one medical expert described as a "game-changing" product for women in an underserved market segment.

Clearblue, a P&G (NYSE: PG) subsidiary and world’s best-selling brand of home pregnancy and fertility tests, launched the Clearblue Menopause Stage Indicator. It’s the only product that tests hormone levels in combination with a woman’s age and cycle history to show a likely menopause stage on a mobile app, according to Clearblue Brand Director Leah…

Previous Citizens Insurance sees drop in new lawsuits
Next The Petri Dish: Boston Scientific device succeeds in trial, Sanofi vet joins Flagship